View Older Stories View More Recent Stories

Feb 4, 2014 10:44AM Notable Analyst Rating Changes 02/04: (ZNGA) (MRK) (WETF) Upgraded; (HP) (NEM) (TTWO) Downgraded
Feb 4, 2014 08:06AM Roth Capital Starts Kindred Biosciences (KIN) at Buy
Feb 4, 2014 07:28AM Roth Capital Transfers Coverage/Upgrades Salesforce (CRM) to Buy
Feb 3, 2014 09:55AM Roth Keeps Ligand (LGND) at Buy; BD Indication for Promacta is Pleasant Surprise
Jan 31, 2014 09:05AM Top Image Systems, Ltd. Prices $13.1 Million Public Offering of Ordinary Shares
Jan 31, 2014 09:00AM Montage Technology Group Limited Announces Pricing of Follow-On Public Offering
Jan 30, 2014 06:08PM Top Image Systems (TISA) to Offer Common Stock
Jan 30, 2014 04:03PM Top Image Systems, Ltd. Announces Proposed Public Offering of Ordinary Shares
Jan 24, 2014 11:39AM Rexahn Pharma (RNN) Rises Back Above $1 Level with Volume
Jan 24, 2014 09:03AM Derma Sciences (DSCI) Prices 6.5M Offering at $11.50/Share
Jan 24, 2014 08:29AM Roth Capital Resumes GenVec (GNVC) at Buy; Novartis (NVS) Program Reinvigorates Excitement
Jan 24, 2014 08:21AM Tonix Pharma (TNXP) Prices 2.9M Common Offering at $15 Apiece
Jan 23, 2014 06:55AM Keryx Biopharma (KERX) Prices 6.9M Offering at $14.50/Share
Jan 21, 2014 09:33AM Roth Capital Boosts PT on Keryx Biopharma (KERX) to $30 Following Ferric Citrate Approval in Japan
Jan 21, 2014 06:50AM Roth Capital Starts BioCryst Pharma (BCRX) at Buy
Jan 17, 2014 09:14AM Roth Capital Starts Paramount Gold and Silver (PZG) at Buy
Jan 16, 2014 09:13AM Dendreon (DNDN) Updates Outlook, But Concerns with Provenge Remain; Roth Reiterates 'Sell"
Jan 16, 2014 07:30AM Keryx Biopharma (KERX) Well-Positioned for Zerenex Approval in 2014 - Roth Capital
Jan 15, 2014 09:00AM Rexahn Pharma (RNN) Announces $20M Registered Direct Offering
Jan 14, 2014 09:24AM Regeneron (REGN) Remains Strong Buy Following Recent Positive News - Roth Capital
Jan 14, 2014 08:37AM Roth Capital Raises PT on Galena Biopharma (GALE) Following Deal with Dr. Reddy's (RDY)
Jan 14, 2014 06:55AM Concert Pharmaceuticals (CNCE) Files $74.75M IPO
Jan 13, 2014 03:01PM Notable 52-Week Highs and Lows of the Day 01/13: (RNN) (NVAX) (SWKS) High; (LULU) (SODA) Low
Jan 13, 2014 02:45PM Roth Capital Keeps ImmunoCellular (IMUC) at Neutral; Sidelined Until More ICT-107 Answers Appear
Jan 13, 2014 10:27AM Applied Genetic Technologies (AGTC) Files $70M IPO
Jan 13, 2014 10:15AM Notable Mergers and Acquisitions of the Day 01/13: (BEAM) (GG) (GALE) (FWLT) (VC)/(JCI)
Jan 13, 2014 09:31AM Roth Capital Raises PT on Galena Biopharma (GALE) Following Mills Pharmaceuticals Purchase
Jan 13, 2014 07:37AM Galena Biopharma (GALE) Acquires GALE-401 Rights Owner, Mills Pharmaceuticals
Jan 13, 2014 07:05AM Galena Biopharma Acquires Mills Pharmaceuticals, LLC
Jan 10, 2014 08:00AM Retrophin (RTRX) Prices 4.7M Common Offering at $8.50/Share
Jan 10, 2014 07:50AM Roth Capital Sees Synta Pharma (SNTA) Ganetespib Trial Updates as Positive; Affirms 'Buy' Rating
Jan 9, 2014 02:58PM Notable 52-Week Highs and Lows of the Day 01/09: (RNN) (M) (WAG) High; (MRGE) (LULU) Low
Jan 9, 2014 02:19PM Roth Capital Keeps Sunesis Pharma (SNSS) at Buy; Hematology Expansion Positive, Eyes Still on VALOR
Jan 9, 2014 01:01PM Roth Capital Starts Rexahn Pharma (RNN) at Buy; Pieces in Place for Ground-Floor Opportunity
Jan 9, 2014 10:58AM Notable Analyst Rating Changes 01/09: (JCP) (M) (AET) Upgraded; (BWLD) (S) (NVDA) Downgraded
Jan 9, 2014 09:39AM Pre-Open Stock Movers 1/9: (ICPT) (CRDC) (F) Higher; (YRCW) (FDO) (PIR) Lower (more...)
Jan 9, 2014 08:19AM Roth Capital Starts Rexahn Pharmaceuticals Inc. (RNN) at Buy
Jan 8, 2014 01:42PM PlacementTracker Publishes 2013 PIPE Market League Tables
Jan 7, 2014 09:27AM Roth Capital Starts ANI Pharmaceuticals (ANIP) at Buy
Jan 3, 2014 10:29AM Notable Analyst Rating Changes 01/03: (SIRI) (FNSR) (PPL) Upgraded; (EXC) (MU) (S) Downgraded
Jan 3, 2014 09:28AM Pre-Open Stock Movers 1/3: (FEYE) (GV) (FNSR) Higher; (RFIL) (JMBA) (S) Lower (more...)
Jan 3, 2014 08:23AM Roth Capital Starts FX Energy (FXEN) at Buy
Dec 23, 2013 09:34AM Pre-Open Stock Movers 12/23: (DRCO) (XRTX) (APPL) Higher; (TSRO) (MU) (TIF) Lower (more...)
Dec 23, 2013 09:20AM Can-Fite BioPharma (CANF) Target Raised to $28 at Roth Capital
Dec 23, 2013 09:11AM UPDATE: Roth Capital Upgrades Skullcandy (SKUL) to Buy
Dec 23, 2013 07:48AM Ur-Energy (URG) Closes Pathfinder Mines Corp Acquisition
Dec 20, 2013 08:38AM Roth Capital resumed Digital Generation (DGIT) at Buy
Dec 19, 2013 08:15AM Roth Capital Starts Synergy Resources Corporation (SYRG) at Buy
Dec 19, 2013 08:02AM GigOptix (GIG) Prices 8.33M Offering at $1.42/Share
Dec 19, 2013 07:21AM Roth Capital Starts Diamondback Energy (FANG) at Buy
View More Recent Stories View Older Stories